Literature DB >> 12494831

Healing venous ulcers with cycloidal multidirectional vibration therapy.

J M Wilson1, Y M Arseculeratne, Y Yang, G W Cherry.   

Abstract

OBJECTIVE: This preliminary study combined compression bandaging with cycloidal vibration to determine whether this would enhance the rate of healing of venous leg ulceration.
METHOD: Twenty-one patients with venous ulceration were enrolled into a 12-week trial. The vibration device was used three times daily for 30 minutes on each occasion, along with compression bandaging.
RESULTS: Ulcers of 13 patients (62%) healed within 12 weeks. The remaining eight patients completed the 12-week study with a 31-90% reduction in ulcer size. A reduction in pain was observed in 17 out of 21 patients (81%). Ultrasound measurements showed reduced fluid content in the upper dermis in patients whose ulcers had healed and in others whose ulcers were improving.
CONCLUSION: This preliminary study shows that gentle cycloid vibration, combined with standard compression bandaging, enhances the healing rate of venous ulcers and helps to relieve pain.

Entities:  

Mesh:

Year:  2002        PMID: 12494831     DOI: 10.12968/jowc.2002.11.10.26446

Source DB:  PubMed          Journal:  J Wound Care        ISSN: 0969-0700            Impact factor:   2.072


  3 in total

1.  Effect of Vibration on Alleviating Foot Pressure-Induced Ischemia under Occlusive Compression.

Authors:  Weiyan Ren; Mingzheng Zhang; Hongmei Liu; Yih-Kuen Jan; Fang Pu; Yubo Fan
Journal:  J Healthc Eng       Date:  2021-10-25       Impact factor: 2.682

2.  Feasibility study to evaluate cycloidal vibration therapy for the symptomatic treatment of intermittent claudication.

Authors:  Leanne Atkin; John Stephenson; Karen Ousey
Journal:  Pilot Feasibility Stud       Date:  2019-11-17

3.  Pain in persons with chronic venous leg ulcers: A systematic review and meta-analysis.

Authors:  Lena Leren; Edda Johansen; Hilde Eide; Ragnhild S Falk; Lene K Juvet; Tone M Ljoså
Journal:  Int Wound J       Date:  2020-01-03       Impact factor: 3.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.